Subscribe to our RSS feeds RSS    
 

 PSA Articles

PSA Density More Predictive

Jody A. Charnow May 01, 2008

PSA density is strongly associated with pathological stage and biochemical-free survival after radical prostatectomy for prostate cancer, researchers conclude.
 

PSA Testing Varies by Race

Jody A. Charnow May 01, 2008

Black men may be getting the message that they are at increased risk of prostate cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention (2008;17:636-644).
 

TRUS Alone is Not Enough for Prostate Cancer Detection

Jody A. Charnow April 11, 2008

GRAY-SCALE transrectal ultrasonography (TRUS) alone has a limited potential to detect prostate cancer, particularly in patients with total PSA levels below 20 ng/mL, researchers reported in the Journal of Medical Imaging and Radiation Oncology (2008;52:24-28).
 

Elevated PSA Often Meets with Delayed Response

Jody A. Charnow April 07, 2008

DELAYED CLINICIAN response to a patient's abnormal PSA level occurs in about 23% of cases, which may be more common than generally appreciated, according to researchers.
 

TRUS Alone Not Enough for PCa Detection

Jody A. Charnow February 08, 2008

Grey-scale transrectal ultrasonography (TRUS) alone has a limited potential to detect prostate cancer, particularly in patients with total PSA levels below 20 ng/mL, researchers reported in the Journal of Medical Imaging and Radiation Oncology (2008;52:24-28).
 

Hemodilution Lowers PSA Levels

Jody A. Charnow January 01, 2008

HEMODILUTION from increased circulating plasma volumes could explain why obese men with prostate cancer have lower serum PSA levels than non-obese men with the malignancy, according to researchers.
 

Antibody Assay Could Aid in Assessing Prostate Disease

Jody A. Charnow January 01, 2008

Using an assay they developed to detect antibodies to Propionibacterium acnes bacteria, researchers have found a link between these bacteria and development of inflammation-related prostate diseases.
 

Lower PSA Linked to Greater Plasma Volume in Obese PCa Patients

Jody A. Charnow November 20, 2007

Hemodilution from increased circulating plasma volumes could explain why obese men with prostate cancer have lower serum PSA levels than non-obese men with the malignancy, according to researchers.
 

PSA Density Predicts PSA Velocity, UK Study Shows

Jody A. Charnow November 01, 2007

PSA density is an independent determinant of PSA velocity in untreated localized prostate cancer, a study in the UK concluded.
 

Novel Agent May Benefit Men with Metastatic HRPC

John Schieszer September 10, 2007

CHICAGO – A new compound that specifically inhibits production of the cell-survival protein clusterin appears to be well tolerated and produces PSA responses when given in combination with docetaxel and prednisone in men with metastatic hormone refractory prostate cancer (HRPC), a study found.
 
 
A Haymarket Media, Inc website
Home | News | Departments | Editorial Board | Contact | Subscribe | Advertise | About
From Haymarket Medical the Publishers of:
Monthly Prescribing Reference Nurse Practitioners' Prescribing Reference Physician Assistants' Prescribing Reference
Cortlandt Forum McKnight's Long-Term Care News Renal & Urology News The Clinical Advisor JAAPA McKnight's Assisted Living